The lower immunogenicity of synthetic subunit antigens, compared to live attenuated
vaccines, is being addressed with improved vaccine carriers. Recent reports indicate that …

In the past decade, gold nanoparticles have attracted strong interest from the
nanobiotechnological community owing to the significant progress made in robust and easy …

Vaccines activate suitable immune responses to fight against diseases but can possess
limitations such as compromised efficacy and immunogenic responses, poor stability, and …

Nowadays, gold is used in (nano-) medicine, usually in the form of nanoparticles, due to the
solid proofs given of its therapeutic effects on several diseases. Gold also plays an important …

Since their discovery, therapeutic or prophylactic vaccines represent a promising option to
prevent or cure infections and other pathologies, such as cancer or autoimmune disorders …

The use of nanoparticles for developing vaccines has become a routine process for
researchers and pharmaceutical companies. Gold nanoparticles (GNPs) are chemical inert …

In the pursuit of achieving better therapeutic outcomes in the treatment of HIV, innovative
drug delivery strategies have been extensively explored. Mannose receptors, which are …

Glyco-gold nanoparticles combine in a single entity the peculiar properties of gold
nanoparticles with the biological activity of carbohydrates. The result is an exciting …

HIV/AIDS is one of the worst crises affecting global health and influencing economic
development and social stability. Preventing and treating HIV infection is a crucial task …

AIDS causes increasing mortality every year. With advancements in nanomedicine, different
nanomaterials (NMs) have been applied to treat AIDS and overcome its limitations. Among …